ReachMD
Be part of the knowledge.™Episodes 16-30 of 43
Investigating DLL3-Targeted Immunotherapy: The Potential of T Cells to Fight SCLC
Medical Industry FeatureInvestigating DLL3-Targeted Immunotherapy: The Potential of T Cells to Fight SCLC
Addressing Hesitancy on Biosimilars: From Development to Clinical Practice
Medical Industry FeatureAddressing Hesitancy on Biosimilars: From Development to Clinical Practice
Navigating mCRC: A Closer Look at Biomarker Testing
Medical Industry FeatureNavigating mCRC: A Closer Look at Biomarker Testing
Tailored to Fit: Precision Medicine in Metastatic CRC
Medical Industry FeatureTailored to Fit: Precision Medicine in Metastatic CRC
Managing Anemia in Patients With Myelofibrosis
Medical Industry FeatureManaging Anemia in Patients With Myelofibrosis
Spleen Volume Reduction & Long-Term Survival in Myelofibrosis
Medical Industry FeatureSpleen Volume Reduction & Long-Term Survival in Myelofibrosis
Durable Hct Control in Patients with Polycythemia Vera
Medical Industry FeatureDurable Hct Control in Patients with Polycythemia Vera
Reviewing a Real Patient’s Experience With Chronic ITP Therapy
Medical Industry FeatureReviewing a Real Patient’s Experience With Chronic ITP Therapy
Comparing Targeted Therapies for Wild-Type RAS Metastatic Colorectal Cancer
Medical Industry FeatureComparing Targeted Therapies for Wild-Type RAS Metastatic Colorectal Cancer
Inflammation Biosimilars: Examining the Totality of Evidence for Approval
Medical Industry FeatureInflammation Biosimilars: Examining the Totality of Evidence for Approval
Treating Advanced MSI-H/dMMR CRC: Data from a Clinical Trial
Medical Industry FeatureTreating Advanced MSI-H/dMMR CRC: Data from a Clinical Trial
Updates in CLL Treatment: 5 Year Follow-up Data from the CLL14 Trial
Medical Industry FeatureUpdates in CLL Treatment: 5 Year Follow-up Data from the CLL14 Trial
Operational Pathways for Biomarker Testing in NSCLC
Medical Industry FeatureOperational Pathways for Biomarker Testing in NSCLC
A Changing Paradigm for Cancer Screening: Exploring Surrogate Endpoints for an Urgent Public Health Concern
Project Oncology®A Changing Paradigm for Cancer Screening: Exploring Surrogate Endpoints for an Urgent Public Health Concern
Understanding Unmet Needs in the Frontline Ph+ ALL Treatment Landscape
Medical Industry FeatureUnderstanding Unmet Needs in the Frontline Ph+ ALL Treatment Landscape
